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Abstract 
Spinophilin is the most abundant protein phosphatase 1 targeting protein in 
the postsynaptic density of dendritic spines. Spinophilin associates with myriad 
synaptic proteins to regulate normal synaptic communication; however, the full 
complement of spinophilin interacting proteins and mechanisms regulating spinophilin 
interactions are unclear. Here we validate an association between spinophilin and the 
scaffolding protein, disks large-associated protein 3 (SAP90/PSD-95 associated protein 
3; SAPAP3). Loss of SAPAP3 leads to obsessive-compulsive disorder (OCD)-like 
behaviors due to alterations in metabotropic glutamate receptor (mGluR) signaling. 
Here we report that spinophilin associates with SAPAP3 in the brain and in a 
heterologous cell system. Moreover, we have found that expression or activation of group 
I mGluRs along with activation of the mGluR-dependent kinase, protein kinase C 
β, enhances this interaction.  Functionally, global loss of spinophilin attenuates 
amphetamine-induced hyperlocomotion, a striatal behavior associated with dopamine 
dysregulation and OCD. Together, these data delineate a novel link between mGluR 
signaling, spinophilin, and SAPAP3 in striatal pathophysiology.  
Keywords: Phosphatases, Signaling, Striatum, Scaffolding Proteins 
1Abbreviations 
SAP90/PSD-95 associated protein 3 – SAPAP3 
Metabotropic glutamate receptor – mGluR 
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Protein kinase C – PKC 
Protein phosphatase 1 – PP1 
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor – AMPAR 
Obsessive Compulsive Disorder – OCD 
Parkinson disease - PD 
Human Embryonic Kidney 293 cell – HEK293 
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Highlights 
 SAPAP3 and mGluR5 co-immunoprecipitate with spinophilin 
 Spinophilin association with SAPAP3 is enhanced by mGluR5 
 Spinophilin association with SAPAP3 is enhanced by PKC activity 
 Spinophilin association with mGluR5 is enhanced by SAPAP3 
 Loss of spinophilin attenuates amphetamine-induced locomotor sensitization 
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Introduction 
Spinophilin knockout mice have deficits in long-term depression (LTD) in the striatum and 
hippocampus (Allen et al., 2006; Di Sebastino et al., 2016) and behavioral pathologies, 
such as enhanced cocaine-induced conditioned place preference (Allen et al., 2006) and 
increased sedation in response to 2 adrenergic agonists (Lu et al., 2010). As spinophilin 
is the major protein phosphatase 1 (PP11) targeting protein in the PSD (Colbran et al., 
1997), many of spinophilin’s functions are thought to be due to alterations in spinophilin-
dependent PP1 targeting. Using a global proteomics analysis of spinophilin 
immunoprecipitates, we have previously reported that spinophilin binding to multiple 
classes of proteins are diminished following dopamine depletion in the striatum (Hiday et 
al., 2017), an animal model of Parkinson disease (PD). One protein that was detected in 
this screen to potentially have a decreased association with spinophilin was SAP90/PSD-
95 associated protein 3 (SAPAP3). 
 
SAPAP3 is implicated in obsessive-compulsive disorder (OCD) pathologies as knockout 
of this protein leads to excessive grooming in mice, causing them to develop facial lesions 
(Welch et al., 2007). These alterations are due to increases in α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid receptor (AMPAR) internalization and alterations in 
synaptic plasticity (Chen et al., 2011; Wan et al., 2011). Furthermore, this internalization 
is caused by excessive metabotropic glutamate receptor (mGluR) 5-dependent activity and 
plasticity (Chen et al., 2011; Wan et al., 2011). Interestingly, others have found that in 
addition to SAPAP3, spinophilin associates with mGluR5 and loss of spinophilin enhances 
mGluR endocytosis (Di Sebastino et al., 2016). Moreover, treatment with the group I 
mGluR agonist, dihydroxyphenylglycine (DHPG), fails to elicit LTD in hippocampus of 
spinophilin KO animals. However, the mechanisms regulating the spinophilin/SAPAP3 
complex are unknown. Here we identify SAPAP3 as a spinophilin interacting protein 
whose association with spinophilin is regulated by mGluR signaling. Specifically, mGluR 
expression and downstream activation of protein kinase C appear to play a role. Moreover, 
we find that SAPAP3 also regulates spinophilin binding to mGluR5. Functionally, we 
observed that a loss of spinophilin attenuates amphetamine-dependent locomotor 
sensitization, a model of dopamine-dependent striatal dysfunction that overlaps with 
compulsive behaviors. Together these data shed mechanistic light on the association of 
spinophilin with SAPAP3 and mGluR5 and delineate a novel potential role for spinophilin 
in striatal pathophysiology. 
 
MATERIALS AND METHODS 
 
Animals. 
Dissected striatum for immunoprecipitations from WT and spinophilin KO animals were 
performed from female 2-month old mice. Dissected forebrains for immunoprecipitations 
from WT and SAPAP3 KO animals were performed from male (N=2, 1 WT and 1 KO) 
and female (N=2, 1 WT and 1 KO) 1-month old mice. Whole brains from these mice were 
a kind gift of Dr. Nicole Calakos (Duke University School of Medicine, Durham, NC). 
Striatal slices for DHPG studies were prepared from female, 1.5-3.5-month old mice. For 
amphetamine-sensitization studies, 3 – 5.5-month old male spinophilin KO (B6N(Cg)-
Ppp1r9btm1.1(KOMP)Vlcg/J N=6) or male (N=4) or female (N=2) control, WT littermate mice 
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were used. The KO and WT mice from above had previously been subjected to rotarod 
analysis (Edler et al., 2018). All animal experiments were conducted under the guidelines 
of the Guide for the Care and Use of Laboratory Animals (NIH) and approved by the 
Indiana University-Purdue University School of Science Institutional Animal Care and Use 
Committee. 
 
Generating DNA constructs. 
The templates for the constructs used were: human spinophilin (Hiday et al., 2017); rat 
SAPAP3 (Uniprot ID P97838; Addgene 40217, Cambridge, MA); mouse mGluR5 
(Uniprot ID Q3UVX5; Transomic Technology, Huntsville, AL BC144727); human 
PKCUniprot ID P05771; Transomic Technology BC036472); human PP1Uniprot ID 
P62136; Transomic Technology BC001888); and rat PP1Uniprot ID P63088; 
(Carmody et al., 2008)). PCR products were generated from these template DNAs and 
inserted into pDONR221 (ThermoFisher, Waltham MA) for Gateway cloning into either 
pcDNA3.1/nV5-DEST (SAPAP3) or modified pcDNA3.1 vectors containing an HA-tag 
(spinophilin) His-tag (mGluR5), or myc-tag (PKC, PP1, PP11, mGluR5) in place of 
the V5 tag. Spinophilin fragments and F451A mutant were generated from the full-length 
construct. PCRs (cloning or mutagenesis) were performed with Q5 Hot Start high-fidelity 
TAQ polymerase (New England Biolabs, Ipswich, MA), VAPRase (Vanderbilt Antibody 
Protein Resource, Vanderbilt University, Nashville TN), or a site-directed mutagenesis kit 
(QuickChange II, Agilent Technologies, Santa Clara, CA). All constructs and mutations 
were sequence validated (Genewiz, South Plainfield, NJ). 
 
Mammalian cell protein lysis. 
Human embryonic kidney 293FT cells (HEK293; ThermoFisher) were transfected in 25 
cm2 flat bottom flasks with each relevant DNA construct in 500 L serum-free Dulbecco’s 
modified Eagle’s medium using PolyJet reagent (SignaGen Laboratories Rockville, MD) 
in a 3:1 (reagent volume:DNA mass) ratio. Empty vector DNAs were used to transfect 
equal DNA concentrations. Cells were incubated overnight, medium was aspirated from 
each flask, and cells were washed one time with cold phosphate-buffered saline (PBS). 
HEK293 cells were then suspended in a KCl homogenization buffer (150 mM KCl, 50 mM 
Tris-HCl pH 7.5, 1 mM DTT, 2 mM EDTA, 1% Triton X-100) or RIPA homogenization 
buffer (150 mM NaCl, 20 mM Tris-HCl pH 7.5, 1 mM EDTA, 1% NP-40, 1% 
Deoxycholate) containing protease inhibitors (ThermoFisher or Bimake, Houston, TX) and 
phosphatase inhibitors (20 mM sodium fluoride, 20 mM sodium orthovanadate, 20 mM -
glycerophosphate, and 10 mM sodium pyrophosphate; MilliporeSigma, St. Louis, MO or 
ThermoFisher).  
 
PKC activation.  
Prior to harvesting, HEK293 cells were incubated with 200 nM Phorbol 12-myristate 13 
acetate (TPA; Tocris Bioscience, Minneapolis, MN) or vehicle (dimethyl sulfoxide, 
ThermoFisher) for 30 minutes. Following activation, cells were processed as above. 
 
Slice culture pharmacology. 
Slices (400 µm) containing the striatum were made in ice-cold sucrose (206 mM sucrose,  
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2.5 mM KCl, 0.5 mM CaCl2, 7 mM MgCl2, 1.2 mM NaH2PO4, 26 mM NaHCO3, 5 mM 
glucose, 5 mM HEPES.) using a VT1200S vibratome (Leica Biosystems, Buffalo Grove, 
IL). Slices were allowed to equilibrate for 20 minutes in artificial cerebrospinal fluid 
(aCSF; 130 mM NaCl, 3.5 mM KCl, 1.25 mM NaH2PO4, 1.5 mM MgSO4·7 H2O, 2 mM 
CaCl2, 24 mM NaHCO3, 10 mM glucose) prior to treatment. Four striatal slices were 
generated per mouse and two were treated with vehicle and two with DHPG. Slices were 
incubated in a slice chamber at 30ºC for 30 minutes in aCSF with vehicle or 50 µM DHPG 
(Tocris Bioscience). Following incubation, striata were dissected out of the slices and 
spinophilin and SAPAP3 were immunoprecipitated as described below. Two pooled slices 
were used to generate each N and each animal was its own control. 
 
Immunoprecipitation assays. 
HEK293 cell lysates, striatal slices, or dissected striatum were homogenized, sonicated, 
and centrifuged at 10,000 x g for 10 min at 4ºC. HEK293 cell lysates were lysed in KCl or 
RIPA buffer, whereas brain lysates were generated in RIPA or low-ionic (2 mM Tris, 2 
mM EDTA, 1 mM DTT, protease and phosphatase inhibitors as above) buffer. Lysates 
were added to microfuge tubes with appropriate primary antibody: goat spinophilin 
antibody (SC-14774, Santa Cruz Biotechnology, Dallas Texas), SAPAP3 antibody 
(ABN325, MilliporeSigma), mGluR5 antibody (AB5675, MilliporeSigma), HA antibody 
(A190-107A Bethyl Laboratories), HA-magnetic beads (88836, ThermoFisher), c-myc 
antibody (A190-104A, Bethyl Laboratories), goat IgG Isotype Control (02-6202, 
ThermoFisher), or rabbit IgG Isotype control (10500C, ThermoFisher) and incubated at 4 
oC overnight with rotation. Protein G magnetic beads were then added to the samples and 
incubated for 2 h at 4 oC with rotation. Beads were then washed three times with 
immunoprecipitation buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 0.5 % (v/v) Triton 
X-100) using a magnet. Washed beads were incubated with 2X Laemmli sample buffer, 
heated at 70 oC for 10 minutes, separated by SDS-PAGE, and immunoblotted. 
 
Immunoblotting. 
Immunoblotting was performed as previously described (Hiday et al., 2017). Briefly, inputs 
(0.5 % - 2 %) or immunoprecipitates (25 % of the immunoprecipitate) were separated by 
SDS-PAGE and blotted using antibodies to spinophilin, SAPAP3, mGluR5, PP1(SC-
7482; Santa Cruz Biotechnology) PP11 (SC-6108; Santa Cruz Biotechnology), Phospho-
PKC Substrate Motif antibody (6967, Cell Signaling Technology), HA-tag (as above or 
rabbit HA (SC-805, Santa Cruz Biotechnology)), c-myc tag (as above or mouse c-myc (SC-
40, Santa Cruz Biotechnology)). Appropriate infrared secondary antibodies were used 
(Donkey anti goat, donkey anti rabbit, or donkey anti mouse conjugated to Alexa Fluor 690 
or 780; ThermoFisher and Jackson Immunologicals) and imaging and fluorescence 
intensity measurements were made using Image Studio (LI-COR Biosciences, Lincoln, 
NE) set to automatic to ensure no saturated pixels. Linearity of signal intensity was 
validated from 125 ng – 78.3 µg (spinophilin) and from 250 ng to 156.6 µg (SAPAP3 and 
mGluR5) of total lysate loaded (Figure S1). For HEK293 cell immunoblotting 
experiments, each transfection was performed in 25 cm2 flasks isolated on separate days 
and/or from a separate 75cm2 parent flask. Therefore, each transfection set is an 
independent experiment. Each HEK293 immunoblot was analyzed on a separate gel (see 
Quantitation and Statistics, below). For slice studies, 2-3 sets of gels were run with an N 
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of 3-4 on each gel. Samples were normalized to the control values within each gel to allow 
for comparisons across gels. 
 
Mammalian cell imaging 
HEK293 cells were plated in 6-well plates on 18 mm x 18mm x 170nm (LxHxW) 
coverslips (Carl Zeiss Microscopy, Thornwood, NY; 474030-9000-000). Cells were 
stained with V5 rabbit antibody (SC-83849 Santa Cruz Biotechnology; for SAPAP3 
detection), spinophilin goat antibody, and Myc mouse antibody (for mGluR5 detection). 
Primary antibodies were used at a 1:500 concentration. Secondary antibodies were a 
Donkey anti rabbit Alexa-Fluor 546 antibody, Donkey anti goat Alexa-Fluor 488, and a 
Donkey anti mouse Alexa-Flour 647 antibody (ThermoFisher; A10040, A11055, A31571, 
respectively). Secondary antibodies were used at a 1:2000 dilution. No signal was observed 
in non-transfected cells imaged using similar parameters (data not shown). Imaging was 
performed on a Zeiss 710 confocal microscope (Carl Zeiss Microscopy) using Zeiss Elyra 
PS.1 lasers in structured illumination microscopy (SIM) mode (we thank Dr. Teresa 
Mastracci at the Indiana Biosciences Research Institute for use of the Zeiss 710 
microscope). Image processing was performed on Carl Zeiss Zen 2012 SP2 software, 
version 11.03.190 (Carl Zeiss Microscopy). Imaging parameters were set for each channel 
to ensure no saturated pixels. Single optical slices from different fields of view from two 
transfection conditions using SIM were performed. 
 
Amphetamine sensitization. 
For amphetamine-induced behavioral sensitization, WT or whole-body spinophilin KO 
mice (above) were given an intraperitoneal (i.p.) injection of 3.0 mg/kg of d-amphetamine 
(Sigma) or the saline volume equivalent to the control groups. There was an N of 3 in each 
group (WT saline, WT d-amphetamine, spinophilin KO saline, spinophilin KO d-
amphetamine). d-Amphetamine was administered once every 24 hours for five consecutive 
days. Immediately after each i.p. injection, mice were placed in a VersaMax Animal 
Activity Monitoring System (Accuscan Instruments Inc., Columbus, OH). The 40 x 40 cm 
test chamber was equipped with evenly spaced intersecting photocell beams along the walls 
of the test chamber. Interruptions in intersecting photocell beams detected locomotor 
activity. The test chambers were sound-attenuating in that each 40 x 40 cm test chamber is 
situated in a 53 cm across x 58 cm deep x 40 cm high chamber with a house light and fan 
for ventilation and background noise. The VersaMax apparatus is interfaced with a Dell 
computer and the software is programed to track consecutive photocell beam interruptions 
that could be translated into distance traveled (cm). Data was collected in 1-minute 
intervals for 60 minutes. 
 
Quantitation and statistics. 
To normalize immunoprecipitates, the fluorescence intensity of the co-immunoprecipitated 
protein in the immunoprecipitate was divided by the fluorescence intensity of the 
immunoprecipitated protein in the immunoprecipitate as well as the intensity of the co-
immunoprecipitated protein in the lysate. This allows for normalization of 
immunoprecipitation in the different conditions as well as normalizes any protein 
expression differences. To compare across multiple gels, the control and treated normalized 
value was divided by the control normalized value, to give a control value of 1. For 
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comparison of a single control and treated group, a 1-column t-test comparing the treated 
group to a theoretical value of 1 was performed. For comparison of DHPG-treated striatal 
slices, 2-3 sets of gels were run with an N of 3-4 on each gel and a paired t-test was utilized. 
For TPA activation and PKC expression in HEK293 cells and for open-field, a two-way 
ANOVA was performed followed by a Tukey multiple comparison test or Sidak multiple 
comparison test to identify specific differences. Significance values are listed in the 
individual figures and legends. 
 
RESULTS 
Validation of the spinophilin and SAPAP3 protein interaction in mouse brain. 
Mouse striata were homogenized and spinophilin and SAPAP3 immunoprecipitations were 
performed from the lysates. These isolated immunoprecipitates were separated by SDS-
PAGE and immune complexes were analyzed via western blot. Spinophilin 
immunoprecipitates contained SAPAP3 whereas SAPAP3 immunoprecipitates contained 
spinophilin (Fig. 1A). Less co-immunoprecipitation was observed in IgG controls (Fig. 
1A). To further validate this association, we utilized spinophilin KO animals as a control. 
As with IgG control there was more SAPAP3 (1.5 – 3-fold) in the WT when compared to 
the KO control. This was evaluated using two different homogenization buffers. We next 
evaluated SAPAP3 association with spinophilin in SAPAP3 KO mice. Like spinophilin 
KO mice, there was an ~3-fold greater association of spinophilin and SAPAP3 in the WT 
compared to SAPAP3 KO mice (Fig. 1C). Therefore, while there is some non-specific 
binding of SAPAP3 to the spinophilin antibody and spinophilin to the SAPAP3 antibody, 
these data suggest a selective interaction between these two proteins in striatum. 
 
Mechanisms regulating the spinophilin, SAPAP3, mGluR5 complex. 
It was recently shown that spinophilin can anchor to Group I mGluRs to inhibit their 
endocytosis (Sebastiano et al., 2016). We observed SAPAP3 in spinophilin 
immunoprecipitates (Fig. 1) confirming our previous proteomics data (Hiday et al., 2017). 
The above data suggest that spinophilin associates with SAPAP3 and group I mGluRs. 
SAPAP3 has been suggested to play a role in diminishing mGluR5-driven silencing of 
AMPARs in striatal medium spiny neurons (MSNs) (Wan et al., 2011); however, if 
mGluRs modulate the association between spinophilin and SAPAP3 is unknown. In 
agreement with Figure 1, we observed an association between spinophilin and SAPAP3 in 
a heterologous cell system when both spinophilin and SAPAP3 were expressed (Fig. 2A). 
In addition to spinophilin associating with SAPAP3 in heterologous cells, upon co-
expression of mGluR5, there was a dramatic increase in the interaction between spinophilin 
and SAPAP3 (Fig. 2B).  
 To further explore mechanisms modulating the interactions between spinophilin, 
SAPAP3, and mGluR5, we evaluated SAPAP3 in mGluR5 immunoprecipitates in the 
absence or presence of spinophilin. Spinophilin appeared to have no effect on SAPAP3 
binding to mGluR5 (Fig. 2C). However, SAPAP3 expression enhanced the association of 
spinophilin with mGluR5 (Fig. 2D). These data suggest that SAPAP3 and mGluR5 
enhance spinophilin association with mGluR5 and SAPAP3, respectively. 
 While the above data suggest that spinophilin associates with SAPAP3 and 
mGluR5, it is unclear if all three proteins reside in the same area of the cell. We used high-
resolution, SIM imaging to evaluate the localization of the transfected proteins. There were 
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areas of co-localization of all 3 proteins (Fig. S2; white arrowheads). Moreover, histograms 
plotting pixel signal intensity by frequency in each of the 3 channels show areas of single 
protein expression (red, green, or blue), areas of overlap between SAPAP3 and spinophilin 
(yellow), areas of overlap between SAPAP3 and mGluR5 (Purple), areas of overlap 
between spinophilin and mGluR5 (Cyan), and areas where all three proteins co-localize 
(grey). Images from two different transfections and their corresponding histograms are 
shown in Fig. S2, whereas additional images are shown in Fig. S3. These data, along with 
the co-immunoprecipitation data suggest at least indirect, and possibly direct, interactions 
between the 3 proteins. However, while we show multiple cells with a range of transfection 
efficiencies, these data are limited based on image resolution and experimental design. 
Specifically, while SIM imaging has high resolution, the laser intensity may lead to 
detection outside the image plane (e.g. out of focus blurring). Moreover, overexpression of 
any protein may lead to areas of colocalization. 
 
SAPAP3 and mGluR5 bind different domains on spinophilin 
The above data suggest that SAPAP3 and mGluR5 enhance spinophilin binding to each 
individual component. We next delineated the regions on spinophilin that associate with 
SAPAP3 and mGluR5. We expressed deletion mutants of HA-tagged spinophilin (Fig. 3A) 
with SAPAP3 and mGluR5. Previous studies demonstrated that spinophilin associates with 
the PDZ ligand of group I mGluRs (Di Sebastino et al., 2016); however, where on 
spinophilin mGluR5 binds was not elucidated. mGluR5 bound to full-length and 
spinophilin containing amino acids 1-670, but did not bind to amino acids 1-460 or 1-301 
on spinophilin (Fig. 3B). These data suggest that mGluR5 binds to spinophilin in the region 
containing amino acids 1-670 (containing the F-actin binding domain, receptor binding 
domain, and PDZ domain). To narrow this region down, we utilized a second set of 
fragments and found that the domain containing 151-670, but not 441-670, of spinophilin 
bound mGluR5 (Fig. 3C). This suggests that spinophilin binding to mGluR5 requires both 
the receptor binding domain and PDZ domain. Whereas SAPAP3 bound to full-length 
spinophilin, its association with spinophilin lacking the coiled-coil domain was abrogated 
(Fig. 3B). However, binding to additional fragments, including the 665-817 fragment was 
highly variable (data not shown). This may suggest that SAPAP3 binding to spinophilin 
requires the coiled-coil region, but this region is not sufficient for binding.  
 
PKC regulates the spinophilin and SAPAP3 interaction. 
While our data suggest that SAPAP3 binding to spinophilin is regulated by mGluR5, the 
mechanisms by which mGluRs modulate spinophilin/SAPAP3 binding is unclear. mGluR5 
is a Gq-coupled GPCR. Given this, it was of interest to explore the effects of protein kinase 
C beta (PKC), an mGluR5-activated second messenger, on the spinophilin/SAPAP3 
interaction. Among the many PKC isoforms, PKC was selected among others due to its 
high striatal expression observed in the Allen Brain Atlas (Lein et al., 2007). To this end, 
PKC was overexpressed with spinophilin and SAPAP3 in HEK293 cells. Endogenous 
levels of PKC are undetectable (Fig. 4A) and others suggest that PKC is not expressed 
in HEK293 cells (Ludowyke et al., 2006). Mock transfected or PKC transfected cells were 
treated with either vehicle or the phorbol ester, TPA, for 30 minutes prior to processing. 
Following treatment, HA-tagged spinophilin was immunoprecipitated and immune 
complexes were analyzed via western blot (Fig. 4B). In evaluating SAPAP3 expression, a 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 11 
Two-Way ANOVA comparison found a significant effect of activation (F(1,24) = 52.55; 
P<0.0001), PKC expression (F(1,24) = 8.491); P = 0.0076), and an interaction between 
variables (F(1,24) = 9.635; P = 0.0048). A Tukey multiple comparison’s test revealed no 
effect of overexpression of PCKin the non-active conditions on SAPAP3 expression. 
However, activation of endogenous PKC decreased SAPAP3 expression and 
overexpression of PKC under the TPA condition further decreased this expression (Fig. 
4B). This decrease was not due to cell death or regulation of the expression plasmid as 
ponceau stains were equal and there was no difference in the expression of spinophilin 
(Fig. 4B). In evaluating the spinophilin/SAPAP3 interaction, a Two-Way ANOVA 
comparison found a significant effect of both PKC expression (F(1,28)=24.97; P<0.0001) 
and activation (F(1,28)=4.613 P=0.0405) with no interaction effect (F(1,28) = 3.279; 
P=0.0809). A Tukey post-hoc test found a trend for a significant difference in interaction 
upon expression of PKC in the non-activated state (P=0.1338) and a significant effect of 
PKC in the activated state (P = 0.0003). Moreover, activation of overexpressed PKC 
further increased the association compared to PKC expression alone P=0.0429; Fig. 4C). 
Given the TPA-dependent decrease in SAPAP3 protein levels, the increase in association 
may be due to technical floor/ceiling effects; however, there was a significant PKC effect 
by ANOVA and a trend for an increased association between spinophilin and SAPAP3 
when PKC was overexpressed (in the absence of TPA activation), a condition that did not 
alter SAPAP3 expression. These data suggest that activation of PKC decreases SAPAP3 
expression but enhances the spinophilin/SAPAP3 association.  
 
Overexpression of PP1 decreases the interaction between spinophilin and SAPAP3. 
Given the above results suggesting that PKC-specific phosphorylation events play an 
important role on the spinophilin/SAPAP3 interaction, we were further interested to 
investigate the role a specific phosphatase has on the protein interaction. Specifically, the 
importance of PP1, a promiscuous phosphatase targeted to substrates by spinophilin, was 
tested (Fig. 5A). Results showed that in contrast to PKC, PP1 dramatically attenuated 
the spinophilin/SAPAP3 interaction (Fig. 5B). As mGluR5 enhances spinophilin binding 
to SAPAP3, we wanted to determine if overexpression of PP1 modulated the association 
of spinophilin with mGluR5. As with SAPAP3, overexpression of PP1 decreased binding 
of spinophilin with mGluR5 (Fig. 5C, 5D). One possible explanation for overexpression of 
PP1 regulating the spinophilin/SAPAP3/mGluR5 association is that PP1 competitively 
displaces mGluR5 and/or SAPAP3 from spinophilin. To test this, we transfected WT or a 
PP1-deficient binding mutant (F451A) of spinophilin in the presence of SAPAP3 and 
mGluR5 and immunoblotted for spinophilin, SAPAP3, and mGluR5 (Fig. 5E). These 
studies were performed in the absence of overexpressed PP1. WT spinophilin had greater 
endogenous (HEK293 cell) PP1 binding than F451A mutant spinophilin (Fig. 5E). If PP1 
were competing for spinophilin binding to SAPAP3 and mGluR5, we would expect to see 
increased binding of mutant spinophilin; however, we observed no change in binding of an 
F451A mutant spinophilin to either SAPAP3 or mGluR5 (Fig. 5F, 5G). These data 
demonstrate that PP1 expression decreases spinophilin binding to both mGluR5 and 
SAPAP3 and that this decreased association is not due to competition between spinophilin 
and PP1 binding. This suggests a role for PP1 activity on modulating the association of 
spinophilin with mGluR5 and SAPAP3. 
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In vivo regulation of spinophilin SAPAP3 interaction by mGluR signaling 
Whereas mGluR expression and PKC activity modulate spinophilin/SAPAP3 association 
in HEK293 cells, the role of mGluR activation in regulating the spinophilin/SAPAP3 
association in striatum is unclear. To begin to test the role of mGluR activation on 
modulating the spinophilin/SAPAP3 association in neurons, we treated striatal slices from 
adult, wild-type mice with 50 µM DHPG for 30 minutes. Following treatment, striata were 
dissected from the slice and homogenized. Subsequently, spinophilin and SAPAP3 were 
immunoprecipitated and immunoblotted for spinophilin and SAPAP3 (Fig. 6A). DHPG 
treatment on slice cultures caused a trend towards an increased association in the 
spinophilin/SAPAP3 interaction (Fig. 6A). Taken together these data suggest that mGluR5 
activation may enhance the interaction of spinophilin with SAPAP3 in striatal slices (Fig. 
6B); however, there is high variability associated with these assays.  
 
Loss of spinophilin attenuates amphetamine-induced locomotor sensitization. 
SAPAP3 KO mouse models of OCD have alterations in monoamine release and/or 
metabolism (Wood et al., 2018). Moreover, blockade of mGluR5 signaling attenuates 
amphetamine-induced hyperactivity (Gill et al., 2012). Conversely, loss of spinophilin 
enhances responses to cocaine-induced conditioned place preference (Allen et al., 2006). 
However, the role of spinophilin in modulating amphetamine-dependent locomotor 
sensitization has not been evaluated. We treated WT or spinophilin KO mice with 
amphetamine and measured locomotor activity in an open field assay. A Two-Way 
ANOVA demonstrated a trend for a significant Day effect (F (4,16) = 2.468; P = 0.0867), 
a significant genotype effect (F(1,4) = 8.827; P = 0.0411), and a significant interaction 
effect (F(4,16) = 18.80; P<0.0001). Moreover, a Tukey post-hoc test comparing the means 
within each genotype across days shows a significant increase in locomotion in WT 
amphetamine treated animals at days 2 -5 compared to day 1. In contrast, there is no 
difference in locomotor activity in the spinophilin KO mice at days 2-4, and a significant 
decrease at day 5, compared to day 1 (Fig. 7). Furthermore, a Sidak post-hoc test across 
genotypes of amphetamine-treated animals at each day revealed significant differences in 
locomotion between WT and KO animals at days 3-5. These data suggest that loss of 
spinophilin prevents amphetamine-induced locomotor sensitization. 
 
DISCUSSION 
Spinophilin-SAPAP3-mGluR5 association 
Previous studies have identified group I mGluRs in spinophilin immunoprecipitates (Di 
Sebastino et al., 2016). Moreover, our previous studies have detected the mGluR-
interacting protein, homer, in spinophilin immunoprecipitates isolated from WT, but not 
spinophilin KO mice (Baucum et al., 2010). In a recent study using proteomics approaches, 
we found that spinophilin associates with SAPAP3, a regulator of mGluRs (Ade et al., 
2016; Chen et al., 2011), and that this association may be attenuated in animal models of 
PD (Hiday et al., 2017). Our current data demonstrate that spinophilin associates with both 
SAPAP3 and mGluR5 in a heterologous cell system. Moreover, our data suggests that 
spinophilin interacts with SAPAP3 via the coiled-coil region of spinophilin (amino acids 
665-817) whereas it associates with mGluR5 via the receptor binding domain/PDZ domain 
(amino acids 151-670). These data are consistent with previous reports of functional and/or 
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biochemical association of spinophilin with G-protein coupled receptors such as: the D2 
dopamine receptor via amino acids 100-371 on spinophilin (Smith et al., 1999), the 2-
adrenergic receptor via amino acids 169-255 on spinophilin (Richman et al., 2001), the µ-
opioid receptor (Charlton et al., 2008), and the muscarinic M3 receptor (Ruiz de Azua et 
al., 2012). Moreover, our data suggesting that amino acids 151-670 are required for 
mGluR5 binding, complement a recent study that found that spinophilin associates with 
the PDZ binding motif of group I mGluRs (Di Sebastino et al., 2016). The PDZ domain on 
spinophilin contains residues 493-602; however, a fragment containing amino acids 441-
670 of spinophilin was not sufficient to bind mGluR5. Therefore, whereas the PDZ domain 
on spinophilin is required for binding to mGluR5, it is not sufficient for binding. One 
possible explanation is that spinophilin binds mGluR via both the spinophilin receptor 
binding and PDZ domains. This is consistent with observations using rodent spinophilin 
that suggest spinophilin may associate with multiple domains on group I mGluRs (Di 
Sebastino et al., 2016). 
 Genetic deletion of SAPAP3 increases mGluR signaling and leads to motor 
behavior pathologies such as excessive grooming in rodents, a mouse model of OCD (Ade 
et al., 2016; Chen et al., 2011; Wan et al., 2014; Welch et al., 2007). While there is a link 
between group I mGluR signaling and SAPAP3, our data are the first to show that 
spinophilin association with SAPAP3 is enhanced by mGluR5 expression and/or activity. 
Moreover, we also found that SAPAP3 increases targeting of spinophilin to mGluR5. 
Whereas SAPAP3 and mGluR5 bind different domains on spinophilin, we did not directly 
test if SAPAP3 or mGluR5 enhance in vitro binding of spinophilin to mGluR5 and 
SAPAP3, respectively. Given that mGluR5 is a membrane protein, proper folding and 
localization may be important in spinophilin binding and may limit these types of 
approaches. Using immunofluorescence, we observed areas of co-localization between all 
3 proteins in a heterologous cell system. It is important to note that the overlap was not 
complete and there were many areas of co-localization between two of the three proteins. 
Moreover, while we used a high-resolution imaging approach (SIM), these data have 
limitations based on transfection efficiency and imaging resolution/saturation that may 
limit the ability to detect a direct versus indirect interaction. However, taken with the co-
immunoprecipitation data, our data suggest an association between spinophilin, SAPAP3, 
and mGluR5. While our co-isolation studies denote an interaction, we cannot conclude a 
direct interaction between the 3 proteins and future studies will need to use direct 
biochemical analyses in cells (e.g. Förster resonance energy transfer) or in vitro to address 
this question. 
 
Spinophilin/SAPAP3 interaction is regulated by PKC. 
The association of spinophilin with SAPAP3 is enhanced by mGluR5 and the interaction 
between spinophilin and mGluR5 is enhanced by SAPAP3. These data suggest that 
SAPAP3 and mGluR5 may act as a bridge for spinophilin binding. However, in addition 
to this bridge function, we wanted to determine if mGluR signaling may regulate the 
spinophilin/SAPAP3 interaction. Group I mGluRs signal through Gq receptors, activation 
of which increases PKC activity (Niswender and Conn, 2010). Overexpression and 
activation of the striatal enriched PKC isoform, PKC, (Lein et al., 2007) also enhanced 
the association between spinophilin and SAPAP3. It is important to note that 
overexpression and activation of PKC enhanced the association between spinophilin and 
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SAPAP3 by ~3.3-fold in HEK293 cells whereas overexpression of mGluR5 enhanced the 
association of spinophilin with SAPAP3 by ~12-fold. This may suggest both mGluR5-
dependent activation of PKC and possibly bridging may enhance the binding of 
spinophilin with SAPAP3. As Gq-coupled receptors also lead to increases in intracellular 
calcium release, we cannot rule out that calcium is also playing a role in modulating the 
association between spinophilin and SAPAP3.  
 In addition to our heterologous cell studies, we found that activation of striatal 
mGluRs using DHPG showed a trend for an increased interaction between spinophilin and 
SAPAP3 in a slice pharmacology study. We found that treatment of striatal slices with 50 
µM DHPG for 30 minutes increased the association of spinophilin with SAPAP3 by ~1.5-
3-fold. While this increase was not statistically significant, the fold increase was similar to 
what was observed in HEK293 cells. Moreover, it is important to note that the main striatal 
neuron, the GABAergic medium spiny neuron, is separated into direct and indirect pathway 
classes and there may be differential responses in these two classes. Our KO data suggest 
specific, but not completely selective, co-immunoprecipitation of SAPAP3 with 
spinophilin. Therefore, non-specific binding may influence an ability to detect DHPG-
dependent changes in the spinophilin/SAPAP3 interaction. Mechanistically, activation of 
mGluRs by DHPG will increase calcium via both extracellular and intracellular sources as 
well as enhance production of diacylglycerol (DAG) (Wisniewski and Car, 2002). 
Conventional PKC isoforms such as PKC are activated by both calcium and DAG. 
However, in addition to mGluR-dependent regulation of calcium and PKC activity in 
slices, agonist-dependent conformational changes in mGluRs (Niswender and Conn, 2010) 
may also modulate how spinophilin associates with mGluRs and SAPAP3. Conformational 
changes in mGluRs have been previously shown to modulate association with proteins such 
as prion protein (Haas et al., 2014). Moreover, DHPG activation at a higher concentration 
and time (100 µM and 1 hour) has been shown to lead to internalization of mGluRs (Hong 
et al., 2009) which may differentially regulate the spinophilin/SAPAP3 interaction. 
Interestingly, when we incubated striatal slices with 50 µM DHPG for 1 hour, there was 
no difference in the interaction between SAPAP3 and spinophilin and the interaction 
actually trended towards a decrease (24%-32% decrease; data not shown). Therefore, 
increases in mGluR signaling may be counter-balanced by internalization of the receptor. 
Taken together, we cannot completely rule out that alterations in mGluR confirmation, in 
addition to activation of PKC, regulate the spinophilin-SAPAP3 interaction and future 
studies will need to test if conditions that can increase mGluR signaling without 
internalizing the receptor enhance the association between spinophilin and SAPAP3. 
 
Spinophilin/SAPAP3 interaction is regulated by PP1 
Overexpression of the catalytic subunit of PP1 decreased the association of spinophilin 
with mGluR5 and SAPAP3. PP1 binding to spinophilin occurs in a centrally-located PP1 
binding domain containing a key residue, Phe451 (Ragusa et al., 2011; Ragusa et al., 2010). 
Spinophilin targets PP1 to modulate synaptic protein phosphorylation, either by promoting 
dephosphorylation or by inhibiting PP1 activity to increase phosphorylation (Bielas et al., 
2007; Hu et al., 2015; Ragusa et al., 2010). Overexpression of PP1 may compete with 
binding of spinophilin and associated proteins and/or it may regulate spinophilin and 
associated protein phosphorylation in a heterologous cell. SAPAP3 binds to the coiled-coil 
region, upstream of the PP1 binding domain, suggesting that PP1 is not displacing 
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SAPAP3 from spinophilin. Moreover, mutation of the PP1-binding domain on spinophilin 
(F451A) did not modulate the association of spinophilin with mGluR5 or SAPAP3. In 
addition to SAPAP3, overexpression of PP1 significantly decreased spinophilin binding to 
mGluR5. As such, modulation of the spinophilin/mGluR5 interaction by PP1 may be part 
of the reason why the SAPAP3/spinophilin interaction is decreased. Taken together, these 
data suggest PP1-dependent decreases in the association of spinophilin with mGluR5 and 
SAPAP3 may be due to alterations in phosphorylation of any of these proteins and future 
studies will need to delineate specific phosphorylation sites that regulate this interaction. 
 
Spinophilin/SAPAP3/mGluR5 in physiology and OCD 
Spinophilin and mGluR5 both regulate AMPAR function. Specifically, loss of SAPAP3 
increases mGluR5 activity and decreases AMPAR surface expression and activity (Wan et 
al., 2011). Moreover, spinophilin KO or disruption of the spinophilin/PP1 interaction 
decreases AMPAR current rundown (Allen et al., 2006; Yan et al., 1999). In addition to 
AMPAR function, activation of striatal mGluRs induces corticostriatal and hippocampal 
LTD (Sung et al., 2001; Wu et al., 2015). Moreover, loss of SAPAP3 induces a group I 
mGluR-dependent synaptic depression (Chen et al., 2011) and genetic deletion of 
spinophilin abrogates mGluR-dependent LTD (Allen et al., 2006; Di Sebastino et al., 
2016). The above suggest a synaptic physiology link between spinophilin, SAPAP3, and 
mGluR5. Interestingly, we observed behavioral changes in spinophilin KO animals that are 
also associated with behavioral changes in OCD. On the first day, there were no deficits in 
locomotion between the WT and Spinophilin KO animals in either the saline-treated or 
amphetamine treated mice. This is consistent with a previous study showing no difference 
in open field time following a single, 10-minute recording in the open field in young adult 
mice (Wu et al., 2017). However, we found that loss of spinophilin attenuates 
amphetamine-induced locomotor sensitization, a behavior associated with OCD, in young 
adult (~3-6 months of age) mice. Interestingly, the previous study by Wang and colleagues 
found that older (11-13 months) spinophilin KO animals have greater locomotion in the 
open field compared to WT animals (Wu et al., 2017). Moreover, we have previously found 
that striatal spinophilin interactions are altered in adult mice compared to weanlings 
(postnatal day 21) (Baucum et al., 2012). Future studies will need to determine if loss of 
spinophilin attenuates more specific OCD-like behaviors (e.g. quinpirole-induced 
checking) and if loss of spinophilin can ameliorate the excessive grooming observed in a 
SAPAP3 KO model of OCD (Welch et al., 2007). In addition, the age-dependence of these 
changes needs to be evaluated. However, our data suggest a functional role of spinophilin 
in modulating amphetamine-induced striatal locomotor learning pathologies. 
  
Conclusion 
Taken together, our data are the first to describe mechanisms modulating the interaction 
between spinophilin and SAPAP3 and have potential implications in normal striatal MSN 
physiology and biochemical pathologies in striatal MSNs associated with PD and OCD. 
Future studies will need to delineate how modulation of the spinophilin/mGluR5/SAPAP3 
complex regulates MSN function and striatal disease pathology. 
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Figure Legends 
 
Figure 1. Spinophilin and SAPAP3 interact in striatal lysates.  
Striata from WT, spinophilin KO, or SAPAP3 KO mice were homogenized in RIPA (1A, 
1B) or low-ionic (1B, 1C) buffer and immunoprecipitated with goat or rabbit IgG, goat 
spinophilin, or SAPAP3 rabbit antibody as detailed. Immunoprecipitates were 
immunoblotted with the same antibodies.  
 
Figure 2. mGluR5 and SAPAP3 coordinate spinophilin binding in a heterologous cell 
system. 
HEK293 cells were transfected with HA-tagged spinophilin, V5-tagged SAPAP3, and 
Myc-tagged mGluR5. A. Transfected lysates were immunoprecipitated with HA or Myc 
antibodies and immunoblotted with spinophilin, SAPAP3, and mGluR5 antibodies. B. 
Overexpression of mGluR5 significantly increased the amount of SAPAP3 in spinophilin 
immunoprecipitates. C. Overexpression of spinophilin had no significant effect on the 
association of SAPAP3 with mGluR5. D. SAPAP3 overexpression significantly enhanced 
the association of spinophilin with mGluR5. E. Schema of SAPAP3/mGluR5-dependent 
bridging of spinophilin. ** p<0.01, *** p <0.001. 
 
Figure 3. Mapping the domains on spinophilin that interact with SAPAP3 and 
mGluR5.  
HEK293 cells were transfected with SAPAP3 and mGluR5 along with different deletion 
mutants of spinophilin. A. Schematic representation of spinophilin deletion mutants. 
Numbers refer to amino acids on different spinophilin fragments. B. HEK293 cells were 
transfected with SAPAP3 and mGluR5 alone or in the presence of different HA-tagged 
spinophilin deletion mutants. HEK293 cell lysates were immunoprecipitated with an HA 
antibody and immunoprecipitates were immunoblotted for SAPAP3, mGluR5, and HA. C. 
A different set of HA spinophilin fragments were immunoprecipitated and immunoblotted 
for HA and mGluR5. Experiments are representative of 3 independent trials. 
 
Figure 4. Activation of PKC enhanced spinophilin/SAPAP3 interaction. 
HEK293 cells were transfected with spinophilin and SAPAP3 in the absence or presence 
of PKC. The following day, HEK293 cells were treated with 200 nM TPA or vehicle for 
30 minutes. A. Lysates were immunoprecipitated with an HA spinophilin antibody and 
lysates and immunoprecipitates were stained with Ponceau S and immunoblotted for 
spinophilin, SAPAP3, PKC, and PKC substrate substrate antibody. B. Activation of PKC 
and overexpression of PKC along with activation of PKC significantly decreased the 
expression of SAPAP3 compared to: no overexpression or activation (* symbol), PKC 
overexpression only (# symbol), or activation only ($ symbol). C. Activation of PKC along 
with overexpression of PKC significantly increased the association between spinophilin 
and SAPAP3. *,#,$ p<0.05, $$ p<0.01, ***, ### p <0.001, **** p<0.0001. 
 
Figure 5. Overexpression of PP1 decreased spinophilin binding to mGluR5 and 
SAPAP3. 
HEK293 cells were transfected with SAPAP3 and mGluR5 and/or spinophilin in the 
absence or presence of PP1. A. HA immunoprecipitates and/or lysates were 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 21 
immunoblotted with spinophilin, SAPAP3 and Myc antibodies. B. Overexpression of PP1 
significantly decreased SAPAP3 association with spinophilin. C. HA immunoprecipitates 
and/or lysates were immunoblotted with spinophilin, mGluR5, and Myc antibodies. D. 
Overexpression of PP1 decreased mGluR association with spinophilin. E. WT or F451A 
(FA) mutant spinophilin were transfected with SAPAP3 and mGluR5. Mutant spinophilin 
did not bind endogenous PP1, but had no effect on the association of spinophilin with 
SAPAP3 (F) or mGluR5 (G). **P<0.01, ****P<0.0001. 
 
Figure 6. Association of spinophilin with SAPAP3 following DHPG activation of 
mGluRs. 
Striatal slices were incubated with DHPG or vehicle for 30 minutes. Following incubation, 
striata were dissected and immunoprecipitated for spinophilin and SAPAP3. A. 
Immunoblots of control and treated striatal lysates and spinophilin and SAPAP3 
immunoprecipitates. B. Activation of group I mGluRs led to a trend towards an increase in 
the association of spinophilin with SAPAP3. 
 
Figure 7. Spinophilin KO mice do not undergo amphetamine-dependent sensitization. 
Spinophilin KO or WT control littermates were injected with saline or d-amphetamine 
daily for 5 days. Immediately following injection, animals were placed in an open-field 
chamber and total distance traveled over 60 minutes was evaluated. Amphetamine treated 
WT animals had increasing levels of distance traveled on days 2-5 compared to day 1 ($ 
symbols). In contrast, spinophilin KO mice had no change in travel on days 2-4 and a 
decrease in distance traveled on day 5 (# symbol). Moreover, there was a greater distance 
traveled in the WT compared to KO spinophilin mice on days 3, 4, and 5 (* symbols). 
(#P<0.05, ** and $$ P< 0.01, *** P<0.001, and $$$$ P<0.0001). 
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Highlights 
 SAPAP3 and mGluR5 co-immunoprecipitate with spinophilin 
 Spinophilin association with SAPAP3 is enhanced by mGluR5 
 Spinophilin association with SAPAP3 is enhanced by PKC activity 
 Spinophilin association with mGluR5 is enhanced by SAPAP3 
 Loss of spinophilin attenuates amphetamine-induced locomotor sensitization 
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